Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan...
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.
Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in...
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
- Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most...
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)